SEARCH

SEARCH BY CITATION

References

  • Blobe G. C., Stribling D. S., Fabbro D., Stabel S. and Hannun Y. A. (1996) Protein kinase C beta II specifically binds to and is activated by F-actin. J. Biol. Chem. 271, 1582315830.
  • Bolan E. A., Kivell B., Jaligam V. et al. (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol. Pharmacol. 71, 12221232.
  • Boudanova E., Navaroli D. M., Stevens Z. and Melikian H. E. (2008) Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization. Mol. Cell. Neurosci. 39, 211217.
  • Bowton E., Saunders C., Erreger K. et al. (2010) Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J. Neurosci. 30, 60486057.
  • Chen R., Furman C. A., Zhang M., Kim M. N., Gereau R. W. 4th, Leitges M. and Gnegy M. E. (2009) Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. J. Pharmacol. Exp. Ther. 328, 912920.
  • Chen R., Furman C. A. and Gnegy M. E. (2010) Dopamine transporter trafficking: rapid response on demand. Future Neurol. 5, 123.
  • Cho D., Zheng M., Min C., Ma L., Kurose H., Park J. H. and Kim K. M. (2010) Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors. Mol. Endocrinol. 24, 574586.
  • Cubeddu L. X. and Hoffmann I. S. (1982) Operational characteristics of the inhibitory feedback mechanism for regulation of dopamine release via presynaptic receptors. J. Pharmacol. Exp. Ther. 223, 497501.
  • Cubeddu L. X., Lovenberg T. W., Hoffman I. S. and Talmaciu R. K. (1989) Phorbol esters and D2-dopamine receptors. J. Pharmacol. Exp. Ther. 251, 687693.
  • Diaz J., Pilon C., Le Foll B., Gros C., Triller A., Schwartz J. C. and Sokoloff P. (2000) Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J. Neurosci. 20, 86778684.
  • Dickinson S. D., Sabeti J., Larson G. A. et al. (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72, 148156.
  • Dunkley P. R., Heath J. W., Harrison S. M., Jarvie P. E., Glenfield P. J. and Rostas J. A. (1988) A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res. 441, 5971.
  • Edwards A. S., Faux M. C., Scott J. D. and Newton A. C. (1999) Carboxyl-terminal phosphorylation regulates the function and subcellular localization of protein kinase C betaII. J. Biol. Chem. 274, 64616468.
  • Eriksen J., Jorgensen T. N. and Gether U. (2010) Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. J. Neurochem. 113, 2741.
  • Foster J. D., Pananusorn B. and Vaughan R. A. (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 277, 2517825186.
  • Furman C. A., Chen R., Guptaroy B., Zhang M., Holz R. W. and Gnegy M. (2009a) Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy. J. Neurosci. 29, 33283336.
  • Furman C. A., Lo C. B., Stokes S., Esteban J. A. and Gnegy M. E. (2009b) Rab 11 regulates constitutive dopamine transporter trafficking and function in N2A neuroblastoma cells. Neurosci. Lett. 463, 7881.
  • Giambalvo C. T. (2004) Mechanisms underlying the effects of amphetamine on particulate PKC activity. Synapse 51, 128139.
  • Giambalvo C. T. and Wagner R. L. (1994) Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes. J. Neurochem. 63, 169176.
  • Hadlock G. C., Nelson C. C., Baucum A. J., 2nd, Hanson G. R. and Fleckenstein A. E. (2011) Ex vivo identification of protein-protein interactions involving the dopamine transporter. J. Neurosci. Methods 196, 303307.
  • Haubrich D. R. and Pflueger A. B. (1982) The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists. Mol. Pharmacol. 21, 114120.
  • Hersch S. M., Yi H., Heilman C. J., Edwards R. H. and Levey A. I. (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J. Comp. Neurol. 388, 211227.
  • Jirousek M. R., Gillig J. R., Gonzalez C. M. et al. (1996) (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e, k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. J. Med. Chem. 39, 26642671.
  • Johnson L. A., Furman C. A., Zhang M., Guptaroy B. and Gnegy M. E. (2005a) Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. Neuropharmacology 49, 750758.
  • Johnson L. A., Guptaroy B., Lund D., Shamban S. and Gnegy M. E. (2005b) Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta. J. Biol. Chem. 280, 1091410919.
  • Jones S. R., Gainetdinov R. R., Hu X. T., Cooper D. C., Wightman R. M., White F. J. and Caron M. G. (1999) Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat. Neurosci. 2, 649655.
  • Lee F. J., Pei L., Moszczynska A., Vukusic B., Fletcher P. J. and Liu F. (2007) Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J. 26, 21272136.
  • Lee F. J., Pei L. and Liu F. (2009) Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia. Synapse 63, 710712.
  • Leitges M., Schmedt C., Guinamard R., Davoust J., Schaal S., Stabel S. and Tarakhovsky A. (1996) Immunodeficiency in protein kinase cbeta-deficient mice. Science 273, 788791.
  • L'Hirondel M., Cheramy A., Godeheu G., Artaud F., Saiardi A., Borrelli E. and Glowinski J. (1998) Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res. 792, 253262.
  • Liu Y. F., Civelli O., Grandy D. K. and Albert P. R. (1992) Differential sensitivity of the short and long human dopamine D2 receptor subtypes to protein kinase C. J. Neurochem. 59, 23112317.
  • Liu G., Ghahremani M. H., Banihashemi B. and Albert P. R. (2003) Diacylglycerol and ceramide formation induced by dopamine D2S receptors via Gbeta gamma -subunits in Balb/c-3T3 cells. Am. J. Physiol. Cell Physiol. 284, C640C648.
  • Loder M. K. and Melikian H. E. (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J. Biol. Chem. 278, 2216822174.
  • Lu D., Yang H., Lenox R. H. and Raizada M. K. (1998) Regulation of angiotensin II-induced neuromodulation by MARCKS in brain neurons. J. Cell Biol. 142, 217227.
  • Mercuri N. B., Saiardi A., Bonci A., Picetti R., Calabresi P., Bernardi G. and Borrelli E. (1997) Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience 79, 323327.
  • Morris S. J., Van H., II, Daigle M., Robillard L., Sajedi N. and Albert P. R. (2007) Differential desensitization of dopamine D2 receptor isoforms by protein kinase C: the importance of receptor phosphorylation and pseudosubstrate sites. Eur. J. Pharmacol. 577, 4453.
  • Namkung Y. and Sibley D. R. (2004) Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J. Biol. Chem. 279, 4953349541.
  • O'Malley H. A., Park Y., Isom L. L. and Gnegy M. E. (2010) PKCbeta co-localizes with the dopamine transporter in mesencephalic neurons. Neurosci. Lett. 480, 4043.
  • Ono Y., Kikkawa U., Ogita K. et al. (1987) Expression and properties of two types of protein kinase C: alternative splicing from a single gene. Science 236, 11161120.
  • Pothos E. N., Przedborski S., Davila V., Schmitz Y. and Sulzer D. (1998) D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells. J. Neurosci. 18, 55755585.
  • Schmitt K. C. and Reith M. E. (2010) Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse. Ann. N. Y. Acad. Sci. 1187, 316340.
  • Sesack S. R., Aoki C. and Pickel V. M. (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14, 88106.
  • Usiello A., Baik J. H., Rouge-Pont F., Picetti R., Dierich A., LeMeur M., Piazza P. V. and Borrelli E. (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408, 199203.
  • Walaas O., Horn R. S. and Walaas S. I. (1997) The protein kinase C pseudosubstrate peptide (PKC19-36) inhibits insulin-stimulated protein kinase activity and insulin-mediated translocation of the glucose transporter glut 4 in streptolysin-O permeabilized adipocytes. FEBS Lett. 413, 152156.
  • Wang Y., Xu R., Sasaoka T., Tonegawa S., Kung M. P. and Sankoorikal E. B. (2000) Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J. Neurosci. 20, 83058314.
  • Wright D. C., Fick C. A., Olesen J. B. and Craig B. W. (2003) Evidence for the involvement of a phospholipase C–protein kinase C signaling pathway in insulin stimulated glucose transport in skeletal muscle. Life Sci. 73, 6171.
  • Xue B., Guo M. L., Jin D. Z., Mao L. M. and Wang J. Q. (2012) Cocaine facilitates PKC maturation by upregulating its phosphorylation at the activation loop in rat striatal neurons in vivo. Brain Res. 1435, 146153.
  • Yang H., Wang X., Sumners C. and Raizada M. K. (2002) Obligatory role of protein kinase Cbeta and MARCKS in vesicular trafficking in living neurons. Hypertension 39, 567572.
  • Yoshihara C., Saito N., Taniyama K. and Tanaka C. (1991) Differential localization of four subspecies of protein kinase C in the rat striatum and substantia nigra. J. Neurosci. 11, 690700.
  • Zapata A., Witkin J. M. and Shippenberg T. S. (2001) Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses. Neuropharmacology 41, 351359.